About Curemart Pharma Private Limited
Data last updated:
Curemart Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC358267.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Indrajit Yadav and Hridya Nand Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 B/M Shop No. – B – 3 Ajit Singh House – Yusuf Sarai, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2024, the company reported a revenue of ₹45.79 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹94,313 (net margin -2.1%) and EBITDA of -₹1.27 Lakh (EBITDA margin -2.8%).
For more details, the company can be reached via its website curemartpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address12 B/M Shop No. – B – 3 Ajit Singh House – Yusuf Sarai, New Delhi, Delhi, India – 110016
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Curemart Pharma Private Limited
The main business activity of Curemart Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curemart Pharma Private Limited FY 2025 filings available
Curemart Pharma Private Limited reported revenue of ₹45.79 Lakh (up 2066% YoY) for FY 2024.
Financial Statement Summary of Curemart Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.27 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹94,313 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curemart Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curemart Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Curemart Pharma Private Limited
Curemart Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chinubhai Pharma Pvt Ltd | ₹46.16 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Ahmedabad, Gujarat, India |
| Kampri Lifescience Private Limited | ₹46.15 Lakh (FY 2024) | •••• | •••• | -78.0% | •••• | Surat, Gujarat, India |
| Gloled Pharma Pvt Ltd | ₹46.06 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Haryana, India |
| Fantasy Pharma Ventures Private Limited | ₹45.9 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Bangalore, Karnataka, India |
| Avtos Life Sciences Private Limited | ₹45.81 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Navi Mumbai, Maharashtra, India |
| Curemart Pharma Private Limited this company | ₹45.79 Lakh (FY 2024) | •••• | •••• | 2066.0% | •••• | New Delhi, Delhi, India |
| Ctga Biopharma India Private Limited | ₹45.77 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Hyderabad, Telangana, India |
| Lograns Pharma Private Limited | ₹45.53 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| D-Cure Pharmaceuticals Private Limited | ₹45.43 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Arcetic Life Sciences Private Limited | ₹45.39 Lakh (FY 2025) | •••• | •••• | 4185.0% | •••• | Pune, Maharashtra, India |
| Lepidus Pharma India Private Limited | ₹45.31 Lakh (FY 2016) | •••• | •••• | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Curemart Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Curemart Pharma Private Limited
Curemart Pharma Private Limited is audited by A G A P & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A G A P & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Curemart Pharma Private Limited
Curemart Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indrajit Yadav | Director | 03 Dec 2019 | 6 Years 10 Months | Current |
| Hridya Nand Yadav | Director | 03 Dec 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Curemart Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curemart Pharma Private Limited
Curemart Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Curemart Pharma Private Limited
Employment history and EPFO contributions of people linked to Curemart Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curemart Pharma Private Limited
Curemart Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Hridya Nand Yadav was appointed as Director on 03 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Curemart Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curemart Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curemart Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curemart Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curemart Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curemart Pharma Private Limited
Curemart Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 December 2019 (7+ years old) and is registered under CIN U24230DL2019PTC358267.
Curemart Pharma reported revenue of ₹45.79 Lakh for FY 2024 (up 2066% YoY).
Curemart Pharma has 2 current directors:
- Indrajit Yadav - Director
- Hridya Nand Yadav - Director
Curemart Pharma reported a net loss of ₹94,313 (net margin -2.1%) and EBITDA of -₹1.27 Lakh (EBITDA margin -2.8%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Curemart Pharma is U24230DL2019PTC358267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curemart Pharma was incorporated on 03 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Curemart Pharma by revenue are Chinubhai Pharma Pvt Ltd, Kampri Lifescience Private Limited, Gloled Pharma Pvt Ltd, Fantasy Pharma Ventures Private Limited, Avtos Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Hridya Nand Yadav was appointed as Director on 03 Dec 2019. Indrajit Yadav was appointed as Director on 03 Dec 2019.
Curemart Pharma can be reached through the website curemartpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Curemart Pharma is at 12 BM Shop No. – B – 3 Ajit Singh House – Yusuf Sarai, New Delhi, Delhi, India – 110016.
Curemart Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.